Home2359 • HKG
add
WuXi AppTec Ord Shs H
Nakaraang pagsara
$101.70
Sakop ng araw
$100.80 - $104.50
Sakop ng taon
$44.30 - $124.70
Market cap
319.99B HKD
Average na Volume
7.04M
P/E ratio
20.37
Dividend yield
1.39%
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 11.14B | 32.01% |
Gastos sa pagpapatakbo | — | — |
Net na kita | — | — |
Net profit margin | — | — |
Kita sa bawat share | 1.02 | 22.89% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 25.16B | 71.50% |
Kabuuang asset | 83.82B | 12.67% |
Kabuuang sagutin | 23.41B | 21.30% |
Kabuuang equity | 60.41B | — |
Natitirang share | 3.43B | — |
Presyo para makapag-book | 5.82 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | — | — |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
WuXi AppTec Co., Ltd. is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
The company is listed in mainland China and Hong Kong. Its H‑shares are constituents of the Hang Seng Index, and its A‑shares are included in the FTSE China A50 Index.
Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. Wikipedia
Itinatag
Dis 1, 2000
Website
Mga Empleyado
37,832
